View of Vol. 52 (2023): Supplement: Mineralocorticoid antagonists in the cardio-renal-metabolic continuum: emerging role of finerenone

Return to Issue Details Vol. 52 (2023): Supplement: Mineralocorticoid antagonists in the cardio-renal-metabolic continuum: emerging role of finerenone Download Download PDF